Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 2, Pages 250
Publisher
MDPI AG
Online
2021-01-12
DOI
10.3390/cancers13020250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Exosome Encapsulated microRNAs as Circulating Diagnostic Marker for Hepatocellular Carcinoma with Low Alpha fetoprotein
- (2020) Suchandrima Ghosh et al. INTERNATIONAL JOURNAL OF CANCER
- Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
- (2020) Xiaoping Pan et al. Frontiers in Oncology
- Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma
- (2020) Yining Wu et al. OncoTargets and Therapy
- Approaches to urinary detection of prostate cancer
- (2019) Jillian N. Eskra et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma
- (2019) Ane Larrabeiti-Etxebarria et al. Cancers
- The association of let‐7c, miR‐21, miR‐145, miR‐182, and miR‐221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low‐risk disease
- (2019) N. Ozgur Kurul et al. PROSTATE
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
- (2019) Xavier Ruiz-Plazas et al. Journal of Translational Medicine
- Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis
- (2019) Maria Barceló et al. Scientific Reports
- Characterization of inflammatory factor-induced changes in mesenchymal stem cell exosomes and sequencing analysis of exosomal microRNAs
- (2019) Chen Huang et al. World Journal of Stem Cells
- Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer
- (2019) Jingpu Wang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The cancer exosomes: Clinical implications, applications and challenges
- (2019) Zhenye Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
- (2019) João Lobo et al. Cells
- Role of miR-221/222 in Tumor Development and the Underlying Mechanism
- (2019) Qian Song et al. Journal of Oncology
- Isolation of Extracellular Vesicles: General Methodologies and Latest Trends
- (2018) Maria Yu. Konoshenko et al. Biomed Research International
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Topic-Based Dissimilarity and Sensitivity Models for Translation Rule Selection
- (2018) M. Zhang et al. JOURNAL OF ARTIFICIAL INTELLIGENCE RESEARCH
- Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1
- (2018) Chen-Fei Zhou et al. ONCOGENE
- miRWalk: An online resource for prediction of microRNA binding sites
- (2018) Carsten Sticht et al. PLoS One
- Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity
- (2017) S. Wani et al. JOURNAL OF BIOTECHNOLOGY
- Liquid biopsy: a step forward towards precision medicine in urologic malignancies
- (2017) Ashley Di Meo et al. Molecular Cancer
- Transcription factor-microRNA associations and their impact on colorectal cancer survival
- (2017) Lila E. Mullany et al. MOLECULAR CARCINOGENESIS
- Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer
- (2017) Qing-biao Chen et al. TUMOR BIOLOGY
- Exosomes in diagnosis and therapy of prostate cancer
- (2017) Jun Pan et al. Oncotarget
- Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
- (2017) Jialin Song et al. Frontiers in Immunology
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma
- (2016) Xiao-yan He et al. CLINICAL CANCER RESEARCH
- Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence
- (2016) Georgios Markozannes et al. EUROPEAN JOURNAL OF CANCER
- Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis
- (2016) Laura Foj et al. PROSTATE
- PSA and beyond: alternative prostate cancer biomarkers
- (2016) Sharanjot Saini CELLULAR ONCOLOGY
- Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
- (2016) Helle Kristensen et al. Oncotarget
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
- (2015) Yusuke Goto et al. BRITISH JOURNAL OF CANCER
- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer
- (2015) C Coarfa et al. ONCOGENE
- Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method
- (2015) Daniel Enderle et al. PLoS One
- The emerging role of Nemo-like kinase (NLK) in the regulation of cancers
- (2015) Ying Huang et al. TUMOR BIOLOGY
- Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients
- (2015) Xiao-Ke Hao et al. OncoTargets and Therapy
- AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
- (2014) J. Yin et al. CANCER RESEARCH
- Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
- (2014) Francesc Xavier Avilés-Jurado et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Seminal plasma as a diagnostic fluid for male reproductive system disorders
- (2014) Andrei P. Drabovich et al. Nature Reviews Urology
- Secreted Heat Shock Protein 90α (HSP90α) Induces Nuclear Factor-κB-mediated TCF12 Protein Expression to Down-regulate E-cadherin and to Enhance Colorectal Cancer Cell Migration and Invasion
- (2013) Wei-Shone Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PTHrP isoforms have differing effect on chondrogenic differentiation and hypertrophy of mesenchymal stem cells
- (2012) Jong-Min Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
- (2011) Mingguo Huang et al. CARCINOGENESIS
- A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins
- (2011) Shivendra Kishore et al. NATURE METHODS
- Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
- (2011) Fulya Yaman Agaoglu et al. TUMOR BIOLOGY
- Tumor Necrosis-Like Weak Inducer of Apoptosis as a Proinflammatory Cytokine in Human Adipocyte Cells: Up-Regulation in Severe Obesity Is Mediated by Inflammation But Not Hypoxia
- (2010) Joan Vendrell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells
- (2009) Katayoon H. Emami et al. PROSTATE
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation